The Proteins of Type IV Secretion System as Promising Candidates for Helicobacter Pylori Vaccine

The Proteins of Type IV Secretion System as Promising Candidates for Helicobacter Pylori Vaccine

Davood Esmaeili

Contact

Azad Khaledi

Contact

Abbas Bahador

Contact

Mashhad University of Medical Sciences

The Proteins of Type IV Secretion System as Promising Candidates for Helicobacter Pylori Vaccine

Article Fingerprint

ReserarchID

F273F

The Proteins of Type IV Secretion System as Promising Candidates for Helicobacter Pylori Vaccine Banner

AI TAKEAWAY

Connecting with the Eternal Ground

Abstract

Helicobacter. pylori is a component of class 1 carcinogens and there is a close association between the incidence of gastric cancer and high prevalence of infection with this bacterium. The risk of gastric cancer associated with H. pylori infection in industrialized and developing countries is estimated to be 80% and 70% respectively. CagA is the important virulence factor in this bacterium and all of the strains involved in gastric cancer are CagA positive. This factor is secreted into host cells by type IV secretion system. CagA and type IV secretion system in H. pylori encoded by the cag pathogenicity islands (cag PAI) that encodes 30 proteins which are necessary for the pilus formation and function of type IV secretion system, so regarding to the role of this secretion system in secreting CagA and its function in pathogenesis and cancer development in humans and the role of different proteins of this secretion system such as canal and pilus formation and their necessity for function of these structures, it is possibly they are be appropriate candidates for design vaccine, because with inhibiting these proteins can stop canal and pilus formation and finally hinder CagA secretion into the host cells.

References

23 Cites in Article

Reference Format

Ji-Ping Cai,Jin-Wei Cheng,Xiao-Ye Ma,Yu-Zhen Li,You Li,Xiao Huang,Rui-Li Wei (2012). Lack of association of conjunctival MALT lymphoma with Chlamydiae or Helicobacter pylori in a cohort of Chinese patients.
D Makola,D Peura,S Crowe (2007). Helicobacter pylori infection and related gastrointestinal diseases.
Yoshan Moodley,Bodo Linz,Robert Bond,Martin Nieuwoudt,Himla Soodyall,Carina Schlebusch,Steffi Bernhöft,James Hale,Sebastian Suerbaum,Lawrence Mugisha,Schalk Van Der Merwe,Mark Achtman (2012). Age of the Association between Helicobacter pylori and Man.
L Pacifico,C Anania,J Osborn,F Ferraro,C Chiesa (2010). Consequences of Helicobacter pylori infection in children.
T Azuma,J Konishi,Y Tanaka,M Hirai,S Ito,T Kato (1994). Contribution of HLA-DQA gene to host's response against Hellcobacter pylori.
Benjamin Chun-Yu Wong,Shiu Lam,Wai Wong,Jian Chen,Ting Zheng,Rui Feng,Kam Lai,Wayne Hu,Siu Yuen,Suet Leung,Daniel Fong,Joanna Ho,Chi Ching,Jun Chen,For The China Gastric Cancer Study Group (2004). Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China.
D Parkin,C Muir,S Whelan,Y Gao,J Ferlay,J Powell (1992). Cancer incidence in five continents.
A De Luca,A Baldi,P Russo,A Todisco,L Altucci,N Giardullo (2003). Coexpression of Helicobacter pylori's proteins CagA and HspB induces cell proliferation in AGS gastric epithelial cells, independently from the bacterial infection.
J Kusters (2001). Recent Developments in Helicobacter pylori Vaccination.
Xavier Calvet,María‐josé Ramírez Lázaro,Philippe Lehours,Francis Mégraud (2013). Diagnosis and Epidemiology of <scp>H</scp>elicobacter pylori Infection.
Y Niv (2008). H pylori recurrence after successful eradication.
K Robinson,R Argent,J Atherton (2007). The inflammatory and immune response to Helicobacter pylori infection.
J Taylor,M Ziman,J Huff,N Moroski,M Vajdy (2000). The Journal of experimental medicine.
Marta Marchetti,Beatrice Aricò,Daniela Burroni,Natale Figura,Rino Rappuoli,Paolo Ghiara (1995). Development of a Mouse Model of Helicobacter pylori Infection that Mimics Human Disease.
M Marchetti,M Rossi,V Giannelli,M Giuliani,M Pizza,S Censini (1998). Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.
C Lee (2001). Vaccination Against Helicobacter pylori in Non-Human Primate Models and Humans.
G Rossi,P Ruggiero,S Peppoloni,L Pancotto,D Fortuna,L Lauretti (2004). Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy.
M Stein,P Ruggiero,R Rappuoli,F Bagnoli (2013). Helicobacter pylori CagA: from pathogenic mechanisms to its use as an anti-cancer vaccine.
P Ruggiero,S Censini (2014). Helicobacter pylori: A Brief History of a Still Lacking Vaccine.
Laurent Terradot,Gabriel Waksman (2011). Architecture of the Helicobacter pylori Cag‐type IV secretion system.
Wolfgang Fischer (2011). Assembly and molecular mode of action of the Helicobacter pylori Cag type IV secretion apparatus.
L Cendron,G Zanotti (2011). Structural and functional aspects of unique type IV secretory components in the Helicobacter pylori cag-pathogenicity island.
K Stingl,S Müller,G Scheidgen-Kleyboldt,M Clausen,B Maier (2010). Composite system mediates two-step DNA uptake into Helicobacter pylori.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Davood Esmaeili. 2015. \u201cThe Proteins of Type IV Secretion System as Promising Candidates for Helicobacter Pylori Vaccine\u201d. Global Journal of Medical Research - C: Microbiology & Pathology GJMR-C Volume 15 (GJMR Volume 15 Issue C3): .

More Citation Formats

Select Citation Style:

Download Citation

Download Article

GJMR Volume 15 Issue C3
Pg. 39- 42

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-C Classification: NLMC Code: WI 387

Submission ReceivedDecember 12, 2014
Peer Review Double Blind
Handling Editor
Accepted January 2, 2015
Published January 15, 2015

Version of record

v1.2

Issue date

August 28, 2015

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Score: 83

Country: Iran

Subject: Global Journal of Medical Research - C: Microbiology & Pathology

Authors: Azad Khaledi, Abbas Bahador, Davood Esmaeili (PhD/Dr. count: 0)

View Count (all-time): 139

Total Views (Real + Logic): 4104

Total Downloads (simulated): 2248

Publish Date: 2015 08, Fri

Monthly Totals (Real + Logic):

Month 1: 44 views
Month 2: 26 views
Month 3: 48 views
Month 4: 35 views
Month 5: 27 views
Month 6: 26 views
Month 7: 33 views
Month 8: 43 views
Month 9: 22 views
Month 10: 42 views
Month 11: 54 views
Month 12: 47 views
Month 13: 36 views
Month 14: 45 views
Month 15: 34 views
Month 16: 22 views
Month 17: 38 views
Month 18: 33 views
Month 19: 37 views
Month 20: 40 views
Month 21: 24 views
Month 22: 40 views
Month 23: 27 views
Month 24: 27 views
Month 25: 36 views
Month 26: 32 views
Month 27: 48 views
Month 28: 20 views
Month 29: 38 views
Month 30: 29 views
Month 31: 34 views
Month 32: 30 views
Month 33: 36 views
Month 34: 34 views
Month 35: 31 views
Month 36: 25 views
Month 37: 42 views
Month 38: 35 views
Month 39: 35 views
Month 40: 15 views
Month 41: 32 views
Month 42: 35 views
Month 43: 15 views
Month 44: 11 views
Month 45: 24 views
Month 46: 29 views
Month 47: 34 views
Month 48: 33 views
Month 49: 24 views
Month 50: 34 views
Month 51: 36 views
Month 52: 40 views
Month 53: 27 views
Month 54: 32 views
Month 55: 22 views
Month 56: 23 views
Month 57: 31 views
Month 58: 30 views
Month 59: 22 views
Month 60: 26 views
Month 61: 19 views
Month 62: 26 views
Month 63: 36 views
Month 64: 29 views
Month 65: 42 views
Month 66: 24 views
Month 67: 28 views
Month 68: 16 views
Month 69: 29 views
Month 70: 19 views
Month 71: 27 views
Month 72: 39 views
Month 73: 22 views
Month 74: 23 views
Month 75: 19 views
Month 76: 35 views
Month 77: 21 views
Month 78: 39 views
Month 79: 14 views
Month 80: 31 views
Month 81: 26 views
Month 82: 27 views
Month 83: 18 views
Month 84: 22 views
Month 85: 28 views
Month 86: 32 views
Month 87: 18 views
Month 88: 35 views
Month 89: 27 views
Month 90: 43 views
Month 91: 30 views
Month 92: 26 views
Month 93: 33 views
Month 94: 40 views
Month 95: 30 views
Month 96: 35 views
Month 97: 45 views
Month 98: 24 views
Month 99: 39 views
Month 100: 41 views
Month 101: 24 views
Month 102: 36 views
Month 103: 21 views
Month 104: 29 views
Month 105: 32 views
Month 106: 29 views
Month 107: 19 views
Month 108: 37 views
Month 109: 47 views
Month 110: 13 views
Month 111: 36 views
Month 112: 35 views
Month 113: 38 views
Month 114: 29 views
Month 115: 36 views
Month 116: 35 views
Month 117: 45 views
Month 118: 23 views
Month 119: 49 views
Month 120: 35 views
Month 121: 22 views
Month 122: 36 views
Month 123: 41 views
Month 124: 33 views
Month 125: 40 views
Month 126: 25 views
Month 127: 36 views
Month 128: 33 views

Total Views: 4104

Total Downloads: 2248

2026 Trends

Published Article

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]